Form D Explorer
Tempest Therapeutics, Inc. · CIK 1544227

Report a data issueCitable research briefCompare issuerPrivate research collection

Tempest Therapeutics, Inc.

CIK 1544227 · Corporation · Inc. DELAWARE · BRISBANE, California · Biotechnology

Filing history at a glance

The reported offering amount was $4,056,552 in the Jun 23, 2026 filing and $7,500,000 in the Oct 14, 2026 filing. The two records may concern different offerings. All 3 stored filings from Apr 3, 2026 to Oct 14, 2026 are original notices.

Filings
3
Original notices
3
Amendments
0
Activity
Apr 3, 2026
through Oct 14, 2026

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Differences between reported disclosures

Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.

Unavailable values are shown as a dash; reported zero remains zero.
FieldJun 23, 2026 · DOct 14, 2026 · DLater minus earlier
Reported offering amount$4,056,552$7,500,000$3,443,448
Reported amount sold$4,056,552$7,500,000$3,443,448
Reported investor count110
Reported minimum investment$0$0$0

Earlier SEC source: 0001193125-26-278048 · Later SEC source: 0001213900-26-109190

Choose filings to compare · Research this issuer step by step

Latest available filing snapshot

Form D · Oct 14, 2026

Reported offering amount
$7,500,000
Reported exemptions
Rule 506(b)
Reported amount sold
$7,500,000

This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.

Shared EDGAR submitting account

These filings share an external submitting CIK in their accession numbers. The account may belong to a filing agent. How EDGAR assigns accession numbers.

Form D filings (3)